GSK-1292263 Uses, Dosage, Side Effects and more
GSK1292263 has been investigated for the treatment of DIABETES MELLITUS, TYPE 2.
| Attribute | Details |
|---|---|
| Trade Name | GSK-1292263 |
| Generic | GSK-1292263 |
| Type | |
| Formula | C23H28N4O4S |
| Weight | Average: 456.56 Monoisotopic: 456.183126572 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
